Finance

Lists
300482:SHE
Guangzhou Wondfo Biotech Co Ltd
CNÂ¥16.68
+0.30%
(+0.050) 1D
Sep 8, 3:04:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300482...
Open
CNÂ¥16.64
High
CNÂ¥16.77
Low
CNÂ¥16.45
Mkt. cap
7.84B
Avg. vol.
7.11M
Volume
3.73M
Dividend
1.32%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 2, 2026
52-wk high
CNÂ¥26.29
52-wk low
CNÂ¥15.47
EPS
-CNÂ¥0.25
Shares outstanding
468.15M
No. of employees
2K
Open
CNÂ¥16.64
High
CNÂ¥16.77
Low
CNÂ¥16.45
Mkt. cap
7.84B
Avg. vol.
7.11M
Volume
3.73M
Dividend
1.32%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 2, 2026
52-wk high
CNÂ¥26.29
52-wk low
CNÂ¥15.47
EPS
-CNÂ¥0.25
Shares outstanding
468.15M
No. of employees
2K
About Guangzhou Wondfo Biotech Co Ltd
CEO-
Employees2.44K
FoundedNov 13, 1992
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
444.52M
396.65M
581.74M
456.76M
Cost of goods sold
212.69M
238.24M
213.83M
164.92M
Cost of revenue
212.69M
238.24M
213.83M
164.92M
Research and development expenses
90.88M
71.60M
73.65M
64.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220.15M
327.80M
177.81M
179.63M
Operating expense
310.42M
396.37M
267.63M
231.80M
Total operating expenses
523.11M
634.61M
481.47M
396.72M
Operating income
-78.59M
-237.96M
100.28M
60.04M
Other non operating income
-9.71M
7.75M
-13.32M
-27.16M
EBT including unusual items
-78.16M
-241.31M
97.18M
43.38M
EBT excluding unusual items
-87.55M
-224.63M
84.28M
43.25M
Income tax expense
-14.38M
-45.22M
11.06M
4.34M
Effective tax rate
18.40%
18.74%
11.38%
10.01%
Other operating expenses
2.04M
3.96M
8.28M
-4.14M
Net income
-55.46M
-196.76M
84.40M
38.12M
Net profit margin
-12.48%
-49.61%
14.51%
8.35%
Earnings per share
-
-
-
-
Interest and investment income
6.67M
28.80M
4.76M
10.37M
Interest expense
-8.89M
-7.00M
-7.45M
-
Net interest expenses
-2.22M
21.80M
-2.68M
10.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.98M
-181.85M
156.39M
123.24M
Gain or loss from assets sale
-2.09K
-318.79K
-
-
AI content may include mistakes. Learn more
Google apps